Takeda Pharmaceutical Company Limited TAK

Company Overview

Takeda Pharmaceutical Company Limited is a global, research-driven biopharmaceutical company headquartered in Japan, operating primarily in the pharmaceutical and biotechnology industries. The company focuses on the discovery, development, manufacturing, and commercialization of prescription medicines, with an emphasis on innovative therapies and specialty care. Its core therapeutic areas include Gastroenterology, Oncology, Rare Diseases, Neuroscience, and Plasma-Derived Therapies, which together represent the majority of its revenue base.

Founded in 1781 as a traditional Japanese medicine wholesaler, Takeda is one of the oldest pharmaceutical companies in the world. Over more than two centuries, it evolved from a domestic medicine supplier into a multinational biopharmaceutical company through sustained investment in research and development and a series of strategic international acquisitions. A pivotal transformation occurred with the acquisition of Shire plc in 2019, significantly expanding Takeda’s global footprint and rare disease portfolio, and repositioning the company as a leading global specialty biopharmaceutical firm.